Liver Angiopoietin‐2 Is a Key Predictor of D e N ovo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals

Recent reports suggested that direct acting antivirals (DAAs) might favor hepatocellular carcinoma (HCC). In study 1, we studied the proangiogenic liver microenvironment in 242 DAA‐treated chronic hepatitis C patients with advanced fibrosis. Angiopoietin‐2 (ANGPT2) expression was studied in tissue (...

Descripción completa

Detalles Bibliográficos
Autores principales: Faillaci, Francesca, Marzi, Luca, Critelli, Rosina, Milosa, Fabiola, Schepis, Filippo, Turola, Elena, Andreani, Silvia, Vandelli, Gabriele, Bernabucci, Veronica, Lei, Barbara, D'Ambrosio, Federica, Bristot, Laura, Cavalletto, Luisa, Chemello, Liliana, Sighinolfi, Pamela, Manni, Paola, Maiorana, Antonino, Caporali, Cristian, Bianchini, Marcello, Marsico, Maria, Turco, Laura, de Maria, Nicola, Del Buono, Mariagrazia, Todesca, Paola, di Lena, Luca, Romagnoli, Dante, Magistri, Paolo, di Benedetto, Fabrizio, Bruno, Savino, Taliani, Gloria, Giannelli, Gianluigi, Martinez‐Chantar, Maria‐Luz, Villa, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175123/
https://www.ncbi.nlm.nih.gov/pubmed/29604220
http://dx.doi.org/10.1002/hep.29911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175123/
https://www.ncbi.nlm.nih.gov/pubmed/29604220
http://dx.doi.org/10.1002/hep.29911

Ejemplares similares